Oral solid dosage forms play a significant role in the healthcare industry today and will continue to do so in the future
According to the requirements of the pharmaceutical industry, modern tableting systems must be energy efficient, flexible and multifunctional for processing increasingly powerful active pharmaceutical ingredients.
GEA provided the answer at ACHEMA 2022, where the machinery and equipment manufacturer and solution provider presented the new NexGen Press, a new tablet press product line.
NexGen Press combines the advantages of GEA's MODUL and PERFORMA rotary table press lines.
The NexGen Press line is not only a combination of existing technologies and available components, but a next generation tablet press for the pharmaceutical industry.
It is therefore a state-of-the-art solution for a wide range of tableting applications.
"The NexGen Press is an example of our approach to digitalisation and modularisation," explains Evelien Devroey, Strategic Business Manager, Pharma Solid Dosage at GEA Pharma & Healthcare.
"By offering one machine with many applications, we are well prepared for the future," she adds.
"Modular design means that a spectrum of containment capabilities (from basic protection to OEB 5) is available on a single platform."
It is also the first machine series compatible with both Wash-Offline (WOL) and Wet-In-Place (WIP) to meet a wide range of customer requirements.
For example, the base model can be upgraded as needed to meet specific process requirements.
Process requirements might include tableting two layers or different cleaning options to further reduce the risk of cross-contamination.
In addition, each machine is intuitive to operate and benefits from a back-to-basics design philosophy.
As with all GEA tablet presses, occupational and product safety, robust functionality, support and after-sales service come as standard.